ACHV
Price:
$4.165
Market Cap:
$143.03M
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.[Read more]
Industry
Biotechnology
IPO Date
1995-10-12
Stock Exchange
NASDAQ
Ticker
ACHV
According to Achieve Life Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.89. This represents a change of -5.35% compared to the average of -4.11 of the last 4 quarters.
The mean historical PE Ratio of Achieve Life Sciences, Inc. over the last ten years is -1.22. The current -3.89 PE Ratio has changed 31.78% with respect to the historical average. Over the past ten years (40 quarters), ACHV's PE Ratio was at its highest in in the December 2019 quarter at -0.45. The PE Ratio was at its lowest in in the December 2015 quarter at -5.24.
Average
-1.22
Median
-1.12
Minimum
-2.74
Maximum
-0.27
Discovering the peaks and valleys of Achieve Life Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 454.76%
Maximum Annual PE Ratio = -0.27
Minimum Annual Increase = -67.72%
Minimum Annual PE Ratio = -2.74
Year | PE Ratio | Change |
---|---|---|
2023 | -2.74 | 342.07% |
2022 | -0.62 | -67.72% |
2021 | -1.92 | 27.82% |
2020 | -1.50 | 454.76% |
2019 | -0.27 | -19.12% |
2018 | -0.33 | -44.85% |
2017 | -0.61 | -18.40% |
2016 | -0.74 | -60.49% |
2015 | -1.88 | 19.23% |
2014 | -1.58 | -58.92% |
The current PE Ratio of Achieve Life Sciences, Inc. (ACHV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.76
5-year avg
-1.41
10-year avg
-1.22
Achieve Life Sciences, Inc.’s PE Ratio is greater than VectivBio Holding AG (-7.94), greater than Icosavax, Inc. (-8.27), greater than Apellis Pharmaceuticals, Inc. (-15.28), greater than iTeos Therapeutics, Inc. (-5.43), greater than TScan Therapeutics, Inc. (-6.03), greater than Day One Biopharmaceuticals, Inc. (-7.39), less than Acumen Pharmaceuticals, Inc. (-2.06), less than X4 Pharmaceuticals, Inc. (7.41), less than Inozyme Pharma, Inc. (-3.48), less than Immix Biopharma, Inc. (-2.98), less than CNS Pharmaceuticals, Inc. (-0.00), less than Hepion Pharmaceuticals, Inc. (-0.15), less than Freeline Therapeutics Holdings plc (-0.57), less than AVROBIO, Inc. (2.07), less than NextCure, Inc. (-0.65), less than CytomX Therapeutics, Inc. (9.19), less than Neoleukin Therapeutics, Inc. (-0.98), less than Spero Therapeutics, Inc. (4.06), less than Assembly Biosciences, Inc. (-2.10), less than Bolt Biotherapeutics, Inc. (-0.37), greater than Coherus BioSciences, Inc. (-4.85), greater than Gracell Biotechnologies Inc. (-12.26),
Company | PE Ratio | Market cap |
---|---|---|
-7.94 | $1.06B | |
-8.27 | $769.04M | |
-15.28 | $5.00B | |
-5.43 | $540.52M | |
-6.03 | $294.00M | |
-7.39 | $1.25B | |
-2.06 | $133.38M | |
7.41 | $109.78M | |
-3.48 | $312.42M | |
-2.98 | $54.08M | |
-0.00 | $4.60M | |
-0.15 | $4.20M | |
-0.57 | $28.28M | |
2.07 | $5.24M | |
-0.65 | $39.73M | |
9.19 | $93.74M | |
-0.98 | $8.20M | |
4.06 | $71.07M | |
-2.10 | $107.81M | |
-0.37 | $24.78M | |
-4.85 | $142.86M | |
-12.26 | $989.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achieve Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Achieve Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Achieve Life Sciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Achieve Life Sciences, Inc. (ACHV)?
What is the highest PE Ratio for Achieve Life Sciences, Inc. (ACHV)?
What is the 3-year average PE Ratio for Achieve Life Sciences, Inc. (ACHV)?
What is the 5-year average PE Ratio for Achieve Life Sciences, Inc. (ACHV)?
How does the current PE Ratio for Achieve Life Sciences, Inc. (ACHV) compare to its historical average?